REGENXBIO (NASDAQ:RGNX – Get Free Report) posted its quarterly earnings results on Tuesday. The biotechnology company reported ($1.43) earnings per share for the quarter, missing the consensus estimate of ($1.27) by ($0.16), Briefing.com reports. The firm had revenue of $22.30 million for the quarter, compared to the consensus estimate of $34.01 million. REGENXBIO had a […]
REGENXBIO (NASDAQ:RGNX) Posts Quarterly Earnings Results, Misses Expectations By $0 16 EPS themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
REGENXBIO (NASDAQ:RGNX – Get Free Report) issued its quarterly earnings data on Tuesday. The biotechnology company reported ($1.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.27) by ($0.16), Briefing.com reports. The firm had revenue of $22.30 million for the quarter, compared to analyst estimates of $34.01 million. REGENXBIO had a […]
REGENXBIO (RGNX) Scheduled to Post Earnings on Tuesday theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven research firms that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective among […]